Smith MR - Search Results

1

Low Level of Blood CD4⁺ T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell Lymphoma.

Judd J, Dulaimi E, Li T, Millenson MM, Borghaei H, Smith MR, Al-Saleem T. Judd J, et al. Among authors: smith mr. Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):83-88. doi: 10.1016/j.clml.2016.11.005. Epub 2016 Nov 30. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28027895

2

The value of transformed lymphocyte count in subclassification of non-Hodgkin's lymphoma by fine-needle aspiration.

Young NA, Al-Saleem TI, Al-Saleem Z, Ehya H, Smith MR. Young NA, et al. Among authors: smith mr. Am J Clin Pathol. 1997 Aug;108(2):143-51. doi: 10.1093/ajcp/108.2.143. Am J Clin Pathol. 1997. PMID: 9260754

3

Utilization of fine-needle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma.

Young NA, Al-Saleem TI, Ehya H, Smith MR. Young NA, et al. Among authors: smith mr. Cancer. 1998 Aug 25;84(4):252-61. Cancer. 1998. PMID: 9723601

4

Coexisting myelodysplasia and myeloproliferative features in a single clone containing 5q-, Ph and i(17q).

Garay CA, Al-Saleem T, Testa JR, Smith MR. Garay CA, et al. Among authors: smith mr. Leuk Res. 1999 Oct;23(10):965-7. doi: 10.1016/s0145-2126(99)00115-0. Leuk Res. 1999. PMID: 10573144

5

Differentiating large cell lymphoma from indolent small B-cell lymphoma in fine needle aspirates using p53, PCNA and transformed lymphocyte count.

Young NA, Ehya H, Klein-Szanto A, Litwin S, Smith MR, al-Saleem T. Young NA, et al. Among authors: smith mr. Acta Cytol. 2000 Jul-Aug;44(4):592-603. doi: 10.1159/000328534. Acta Cytol. 2000. PMID: 10934953

6

Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions.

Wu H, Smith M, Millenson MM, Nicolaou N, Van Deerlin VM, Addya K, Lessin S, Al-Saleem T. Wu H, et al. J Invest Dermatol. 2003 Dec;121(6):1522-30. doi: 10.1046/j.1523-1747.2003.12631.x. J Invest Dermatol. 2003. PMID: 14675205 Free article.

7

Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma.

Ibrahim D, Smith MR, Varterasian M, Karanes C, Millenson M, Yeslow G, Pemberton P, Lai P, Abrams J, Al-Katib A. Ibrahim D, et al. Among authors: smith mr. Leuk Lymphoma. 2004 Oct;45(10):2079-84. doi: 10.1080/1042819042000223831. Leuk Lymphoma. 2004. PMID: 15370253 Clinical Trial.

8

Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.

Borghaei H, Millenson M, Schilder R, Alden M, Rogatko A, Wang H, Padavic-Shaller K, Smith MR. Borghaei H, et al. Among authors: smith mr. Cancer. 2004 Nov 1;101(9):2034-41. doi: 10.1002/cncr.20616. Cancer. 2004. PMID: 15455357 Free article. Clinical Trial.

9

Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.

Morris GJ, Millenson MM, Padavic-Shaller K, Wang H, Rogatko A, Clyde J, Boyd RL, Yeslow G, Halbherr T, Schilder RJ, Smith MR. Morris GJ, et al. Among authors: smith mr. Haematologica. 2004 Dec;89(12):1484-91. Haematologica. 2004. PMID: 15590399 Clinical Trial.

10

Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.

Narra K, Borghaei H, Al-Saleem T, Höglund M, Smith MR. Narra K, et al. Among authors: smith mr. Leuk Res. 2006 Jan;30(1):109-14. doi: 10.1016/j.leukres.2005.05.017. Epub 2005 Jul 25. Leuk Res. 2006. PMID: 16043218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,177 results

Search Page

Filters